Esperion Therapeutics
Price & Volume
Stats
See more52W Range | $0.69-$4.17 |
Market Cap | $559.8M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $403.1M |
Revenue Growth (YoY) | 143.7% |
Gross Profit (12 Mos) | $226M |
Diluted EPS | -$0.11 |
News
See moreYahoo Finance • 8 days ago
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
Yahoo Finance • 11 days ago
Merck oral PCSK9 enlicitide shows improved cholesterol lowering vs. non-statins
About
CEO | Mr. Sheldon L. Koenig M.B.A. |
Address | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 294 |
